<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36979062</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-7737</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Biology</Title><ISOAbbreviation>Biology (Basel)</ISOAbbreviation></Journal><ArticleTitle>Connections between Diabetes Mellitus and Metabolic Syndrome and the Outcome of Cardiac Dysfunctions Diagnosed during the Recovery from COVID-19 in Patients without a Previous History of Cardiovascular Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">370</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biology12030370</ELocationID><Abstract><AbstractText>(1) Background: Throughout the COVID-19 pandemic, it became obvious that individuals suffering with obesity, diabetes mellitus (T2DM), and metabolic syndrome (MS) frequently developed persisting cardiovascular complications, which were partially able to explain the onset of the long-COVID-19 syndrome. (2) Methods: Our aim was to document, by transthoracic echocardiography (TTE), the presence of cardiac alterations in 112 patients suffering from post-acute COVID-19 syndrome and T2DM, MS, and/or obesity, in comparison to 91 individuals without metabolic dysfunctions (MD); (3) Results: in patients with MD, TTE borderline/abnormal left (LVF) and/or right ventricular function (RVF), alongside diastolic dysfunction (DD), were more frequently evidenced, when compared to controls (<i>p</i> &#x2c2; 0.001). Statistically significant associations between TTE parameters and the number of factors defining MS, the triglyceride-glucose (TyG) index, the severity of the SARS-CoV-2 infection, and the number of persisting symptoms (<i>p</i> &#x2c2; 0.001) were noted. Significant predictive values for the initial C-reactive protein and TyG index levels, both for the initial and the 6-month follow-up levels of these TTE abnormalities (<i>p</i> &#x2c2; 0.001), were highlighted by means of a multivariate regression analysis. (4) Conclusions: in diabetic patients with MS and/or obesity with comorbid post-acute COVID-19 syndrome, a comprehensive TTE delineates various cardiovascular alterations, when compared with controls. After 6 months, LVF and RVF appeared to normalize, however, the DD-although somewhat improved-did persist in approximately a quarter of patients with MD, possibly due to chronic myocardial changes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tudoran</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7351-741X</Identifier><AffiliationInfo><Affiliation>Department VII, Internal Medicine II, Discipline of Cardiology, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>County Emergency Hospital "Pius Brinzeu", L. Rebreanu, Nr. 156, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Romanian Scientists, Ilfov Str., Nr. 3, 50085 Bucuresti, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bende</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>County Emergency Hospital "Pius Brinzeu", L. Rebreanu, Nr. 156, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Advanced Research in Gastroenterology and Hepatology, Faculty of Medicine, University of Medicine and Pharmacy "Victor Babes" Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bende</LastName><ForeName>Felix</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3820-7325</Identifier><AffiliationInfo><Affiliation>County Emergency Hospital "Pius Brinzeu", L. Rebreanu, Nr. 156, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Advanced Research in Gastroenterology and Hepatology, Faculty of Medicine, University of Medicine and Pharmacy "Victor Babes" Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department VII, Internal Medicine II, Discipline of Gastroenterology, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giurgi-Oncu</LastName><ForeName>Catalina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8962-0000</Identifier><AffiliationInfo><Affiliation>County Emergency Hospital "Pius Brinzeu", L. Rebreanu, Nr. 156, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department VIII, Neuroscience, Discipline of Psychiatry, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enache</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department VIII, Discipline of Forensic Medicine, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Ethics in Human Genetic Identification, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumache</LastName><ForeName>Raluca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department VIII, Discipline of Forensic Medicine, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Ethics in Human Genetic Identification, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tudoran</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>County Emergency Hospital "Pius Brinzeu", L. Rebreanu, Nr. 156, 300723 Timisoara, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biology (Basel)</MedlineTA><NlmUniqueID>101587988</NlmUniqueID><ISSNLinking>2079-7737</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">diabetes mellitus type 2</Keyword><Keyword MajorTopicYN="N">diastolic dysfunction</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">insulin resistance syndrome</Keyword><Keyword MajorTopicYN="N">metabolic syndrome</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">transthoracic echocardiography</Keyword></KeywordList><CoiStatement>The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36979062</ArticleId><ArticleId IdType="pmc">PMC10044929</ArticleId><ArticleId IdType="doi">10.3390/biology12030370</ArticleId><ArticleId IdType="pii">biology12030370</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonow R.O., Fonarow G.C., O&#x2019;Gara P.T., Yancy C.W. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 2020;5:751. doi: 10.1001/jamacardio.2020.1105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1105</ArticleId><ArticleId IdType="pubmed">32219362</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z., Zhao Y. Prevalence and Impact of Cardiovascular Metabolic Diseases on COVID-19 in China. Clin. Res. Cardiol. 2020;109:531&#x2013;538. doi: 10.1007/s00392-020-01626-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolis A.S., Manolis A.A., Manolis T.A., Apostolaki N.E., Melita H. COVID-19 Infection and Body Weight: A Deleterious Liaison in a J-Curve Relationship. Obes. Res. Clin. Pract. 2021;15:523&#x2013;535. doi: 10.1016/j.orcp.2021.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.orcp.2021.10.006</ArticleId><ArticleId IdType="pmc">PMC8563353</ArticleId><ArticleId IdType="pubmed">34799284</ArticleId></ArticleIdList></Reference><Reference><Citation>Landstra C.P., de Koning E.J.P. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front. Endocrinol. 2021;12:649525. doi: 10.3389/fendo.2021.649525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.649525</ArticleId><ArticleId IdType="pmc">PMC8247904</ArticleId><ArticleId IdType="pubmed">34220706</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendren N.S., Drazner M.H., Bozkurt B., Cooper L.T. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020;141:1903&#x2013;1914. doi: 10.1161/CIRCULATIONAHA.120.047349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047349</ArticleId><ArticleId IdType="pmc">PMC7314493</ArticleId><ArticleId IdType="pubmed">32297796</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong T.-Y., Redwood S., Prendergast B., Chen M. Coronaviruses and the Cardiovascular System: Acute and Long-Term Implications. Eur. Heart J. 2020;41:1798&#x2013;1800. doi: 10.1093/eurheartj/ehaa231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa231</ArticleId><ArticleId IdType="pmc">PMC7454513</ArticleId><ArticleId IdType="pubmed">32186331</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020;5:831. doi: 10.1001/jamacardio.2020.1286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1286</ArticleId><ArticleId IdType="pubmed">32219363</ArticleId></ArticleIdList></Reference><Reference><Citation>Freaney P.M., Shah S.J., Khan S.S. COVID-19 and Heart Failure With Preserved Ejection Fraction. JAMA. 2020;324:1499. doi: 10.1001/jama.2020.17445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17445</ArticleId><ArticleId IdType="pubmed">33001179</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi R.M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D., Cani D.S., Cerini M., Farina D., Gavazzi E., et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:819. doi: 10.1001/jamacardio.2020.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes&#x2014;2020. Diabetes Care. 2020;43((Suppl. 1)):S111&#x2013;S134. doi: 10.2337/dc20-ad08.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-ad08</ArticleId><ArticleId IdType="pubmed">31862753</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.-C., James W.P.T., Loria C.M., Smith S.C. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640&#x2013;1645. doi: 10.1161/CIRCULATIONAHA.109.192644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.192644</ArticleId><ArticleId IdType="pubmed">19805654</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda M., Shimomura I. Increased Oxidative Stress in Obesity: Implications for Metabolic Syndrome, Diabetes, Hypertension, Dyslipidemia, Atherosclerosis, and Cancer. Obes. Res. Clin. Pract. 2013;7:e330&#x2013;e341. doi: 10.1016/j.orcp.2013.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.orcp.2013.05.004</ArticleId><ArticleId IdType="pubmed">24455761</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S., Hussain M.E. Obesity and Diabetes: An Update. Diabetes Metab. Syndr. Clin. Res. Rev. 2017;11:73&#x2013;79. doi: 10.1016/j.dsx.2016.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2016.06.017</ArticleId><ArticleId IdType="pubmed">27353549</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiterer M., Rajan M., G&#xf3;mez-Banoy N., Lau J.D., Gomez-Escobar L.G., Ma L., Gilani A., Alvarez-Mulett S., Sholle E.T., Chandar V., et al. Hyperglycemia in Acute COVID-19 Is Characterized by Insulin Resistance and Adipose Tissue Infectivity by SARS-CoV-2. Cell Metab. 2021;33:2174&#x2013;2188.e5. doi: 10.1016/j.cmet.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8443335</ArticleId><ArticleId IdType="pubmed">34599884</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Liu C., Peng J., Li Z., Li F., Wang J., Hu A., Peng M., Huang K., Fan D., et al. COVID-19 Induces New-Onset Insulin Resistance and Lipid Metabolic Dysregulation via Regulation of Secreted Metabolic Factors. Signal Transduct. Target. Ther. 2021;6:427. doi: 10.1038/s41392-021-00822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00822-x</ArticleId><ArticleId IdType="pmc">PMC8674414</ArticleId><ArticleId IdType="pubmed">34916489</ArticleId></ArticleIdList></Reference><Reference><Citation>Dini F.L., Fabiani I., Miccoli M., Galeotti G.G., Pugliese N.R., D&#x2019;Agostino A., Scartabelli A., Conte L., Salvetti G., Santini F., et al. Prevalence and Determinants of Left Ventricular Diastolic Dysfunction in Obese Subjects and the Role of Left Ventricular Global Longitudinal Strain and Mass Normalized to Height. Echocardiography. 2018;35:1124&#x2013;1131. doi: 10.1111/echo.13890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.13890</ArticleId><ArticleId IdType="pubmed">29664200</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15a;wierblewska E., Wolf J., Kunicka K., Graff B., Polonis K., Hoffmann M., Chrostowska M., Szyndler A., Bandosz P., Graff B., et al. Prevalence and Distribution of Left Ventricular Diastolic Dysfunction in Treated Patients with Long-Lasting Hypertension. Blood Press. 2018;27:376&#x2013;384. doi: 10.1080/08037051.2018.1484661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08037051.2018.1484661</ArticleId><ArticleId IdType="pubmed">30129379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalligeros M., Shehadeh F., Mylona E.K., Benitez G., Beckwith C.G., Chan P.A., Mylonakis E. Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019. Obesity. 2020;28:1200&#x2013;1204. doi: 10.1002/oby.22859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22859</ArticleId><ArticleId IdType="pmc">PMC7267224</ArticleId><ArticleId IdType="pubmed">32352637</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S.R., Rubino F., Ludwig B., Rietzsch H., Schwarz P.E.H., Rodionov R.N., Khunti K., Hopkins D., Birkenfeld A.L., Boehm B., et al. Consequences of the COVID-19 Pandemic for Patients with Metabolic Diseases. Nat. Metab. 2021;3:289&#x2013;292. doi: 10.1038/s42255-021-00358-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00358-y</ArticleId><ArticleId IdType="pubmed">33633407</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C., Tudoran M., Cut T.G., Lazureanu V.E., Bende F., Fofiu R., Enache A., Pescariu S.A., Novacescu D. The Impact of Metabolic Syndrome and Obesity on the Evolution of Diastolic Dysfunction in Apparently Healthy Patients Suffering from Post-COVID-19 Syndrome. Biomedicines. 2022;10:1519. doi: 10.3390/biomedicines10071519.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10071519</ArticleId><ArticleId IdType="pmc">PMC9312435</ArticleId><ArticleId IdType="pubmed">35884823</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Schwarz P.E.H., Ludwig B., Linkermann A., Zimmet P., Kulebyakin K., Tkachuk V.A., Markov A.G., Lehnert H., de Angelis M.H., et al. COVID-19 and Metabolic Disease: Mechanisms and Clinical Management. Lancet Diabetes Endocrinol. 2021;9:786&#x2013;798. doi: 10.1016/S2213-8587(21)00244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00244-8</ArticleId><ArticleId IdType="pmc">PMC8489878</ArticleId><ArticleId IdType="pubmed">34619105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S., Chakraborty R., Kalita P., Pathak M.P. Diabetes Mellitus and COVID-19: Understanding the Association in Light of Current Evidence. WJCC. 2021;9:8327&#x2013;8339. doi: 10.12998/wjcc.v9.i28.8327.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v9.i28.8327</ArticleId><ArticleId IdType="pmc">PMC8554438</ArticleId><ArticleId IdType="pubmed">34754842</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-Acute Sequelae of COVID-19 with a Cardiovascular Focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V.D., Osebold L., et al. Post-COVID Syndrome in Non-Hospitalised Patients with COVID-19: A Longitudinal Prospective Cohort Study. Lancet Reg. Health-Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y., Lichter Y., Taieb P., Banai A., Hochstadt A., Merdler I., Gal Oz A., Rothschild E., Baruch G., Peri Y., et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020;142:342&#x2013;353. doi: 10.1161/CIRCULATIONAHA.120.047971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047971</ArticleId><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik T.J., Mohiddin S.A., Dimarco A., Patel V., Savvatis K., Marelli-Berg F.M., Madhur M.S., Tomaszewski M., Maffia P., D&#x2019;Acquisto F., et al. COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options. Cardiovasc. Res. 2020;116:1666&#x2013;1687. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata H., Mori M., Jingushi Y., Matsuzaki H., Katahira K., Ishimatsu A., Enokizu-Ogawa A., Taguchi K., Moriwaki A., Yoshida M. Impact of Visceral Fat on the Prognosis of Coronavirus Disease 2019: An Observational Cohort Study. BMC Infect. Dis. 2021;21:1240. doi: 10.1186/s12879-021-06958-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06958-z</ArticleId><ArticleId IdType="pmc">PMC8660963</ArticleId><ArticleId IdType="pubmed">34893021</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Lu Y., Huang Y.-M., Wang M., Ling W., Sui Y., Zhao H.-L. Obesity in Patients with COVID-19: A Systematic Review and Meta-Analysis. Metabolism. 2020;113:154378. doi: 10.1016/j.metabol.2020.154378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154378</ArticleId><ArticleId IdType="pmc">PMC7521361</ArticleId><ArticleId IdType="pubmed">33002478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lighter J., Phillips M., Hochman S., Sterling S., Johnson D., Francois F., Stachel A. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin. Infect. Dis. 2020;71:896&#x2013;897. doi: 10.1093/cid/ciaa415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa415</ArticleId><ArticleId IdType="pmc">PMC7184372</ArticleId><ArticleId IdType="pubmed">32271368</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranata R., Lim M.A., Huang I., Yonas E., Henrina J., Vania R., Lukito A.A., Nasution S.A., Alwi I., Siswanto B.B. Visceral Adiposity, Subcutaneous Adiposity, and Severe Coronavirus Disease-2019 (COVID-19): Systematic Review and Meta-Analysis. Clin. Nutr. ESPEN. 2021;43:163&#x2013;168. doi: 10.1016/j.clnesp.2021.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8032475</ArticleId><ArticleId IdType="pubmed">34024509</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco B.N., Asano S. COVID-19-Related Trends and Characteristics of Type 2 Diabetes Mellitus and Metabolic Syndrome. Cureus. 2022;14:e21483. doi: 10.7759/cureus.21483.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.21483</ArticleId><ArticleId IdType="pmc">PMC8859044</ArticleId><ArticleId IdType="pubmed">35223263</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Li G., Cheng T., Liu J., Song G., Ma H. Association between Triglyceride-Glucose Index and Risk of Incident Diabetes: A Secondary Analysis Based on a Chinese Cohort Study. Lipids. Health Dis. 2020;19:236. doi: 10.1186/s12944-020-01403-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12944-020-01403-7</ArticleId><ArticleId IdType="pmc">PMC7649000</ArticleId><ArticleId IdType="pubmed">33161902</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., He G., Lo K., Huang Y., Feng Y. The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-Linear Associated With All-Cause and Cardiovascular Mortality in the General Population. Front. Cardiovasc. Med. 2021;7:628109. doi: 10.3389/fcvm.2020.628109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.628109</ArticleId><ArticleId IdType="pmc">PMC7840600</ArticleId><ArticleId IdType="pubmed">33521071</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Zhu B., Chen D., Hu X., Xu X., Shen W.-J., Hu C., Li J., Qu S. COVID-19 May Increase the Risk of Insulin Resistance in Adult Patients Without Diabetes: A 6-Month Prospective Study. Endocr. Pract. 2021;27:834&#x2013;841. doi: 10.1016/j.eprac.2021.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC8054613</ArticleId><ArticleId IdType="pubmed">33887468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Wang J., Ding X., Chen S., Li J., Shen B. The Correlation Between Triglyceride-Glucose Index and SARS-CoV-2 RNA Re-Positive in Discharged COVID-19 Patients. Infect. Drug. Resist. 2022;15:3815&#x2013;3828. doi: 10.2147/IDR.S368568.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S368568</ArticleId><ArticleId IdType="pmc">PMC9304634</ArticleId><ArticleId IdType="pubmed">35875612</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y., Jeon J., Song T.-J., Kim J. Association of Triglyceride-Glucose Index with Prognosis of COVID-19: A Population-Based Study. J. Infect. Public Health. 2022;15:837&#x2013;844. doi: 10.1016/j.jiph.2022.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.06.014</ArticleId><ArticleId IdType="pmc">PMC9225941</ArticleId><ArticleId IdType="pubmed">35779467</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavazos A.E., Secchi F., Basilico S., Capitanio G., Boveri S., Milani V., Dubini C., Schiaffino S., Morricone L., Foschini C., et al. Abdominal Obesity Phenotype Is Associated with COVID-19 Chest X-Ray Severity Score Better than BMI-Based Obesity. Eat. Weight. Disord. 2022;27:345&#x2013;359. doi: 10.1007/s40519-021-01173-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40519-021-01173-w</ArticleId><ArticleId IdType="pmc">PMC8020829</ArticleId><ArticleId IdType="pubmed">33821453</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohani-Rasaf M., Mirjalili K., Vatannejad A., Teimouri M. Are Lipid Ratios and Triglyceride-Glucose Index Associated with Critical Care Outcomes in COVID-19 Patients? PLoS ONE. 2022;17:e0272000. doi: 10.1371/journal.pone.0272000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272000</ArticleId><ArticleId IdType="pmc">PMC9342722</ArticleId><ArticleId IdType="pubmed">35913952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N., Oh J.K., Smiseth O.A., Waggoner A.D., Flachskampf F.A., Pellikka P.A., Evangelista A. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. J. Am. Soc. Echocardiogr. 2009;22:107&#x2013;133. doi: 10.1016/j.echo.2008.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2008.11.023</ArticleId><ArticleId IdType="pubmed">19187853</ArticleId></ArticleIdList></Reference><Reference><Citation>Baycan O.F., Barman H.A., Atici A., Tatlisu A., Bolen F., Ergen P., Icten S., Gungor B., Caliskan M. Evaluation of Biventricular Function in Patients with COVID-19 Using Speckle Tracking Echocardiography. Int. J. Cardiovasc. Imaging. 2020;37:135&#x2013;144. doi: 10.1007/s10554-020-01968-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-020-01968-5</ArticleId><ArticleId IdType="pmc">PMC7429089</ArticleId><ArticleId IdType="pubmed">32803484</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C., Tudoran M., Cut T.G., Lazureanu V.E., Oancea C., Marinescu A.R., Pescariu S.A., Pop G.N., Bende F. Evolution of Echocardiographic Abnormalities Identified in Previously Healthy Individuals Recovering from COVID-19. J. Pers. Med. 2022;12:46. doi: 10.3390/jpm12010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12010046</ArticleId><ArticleId IdType="pmc">PMC8778114</ArticleId><ArticleId IdType="pubmed">35055360</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayol A., Livrozet M., Boutouyrie P., Khettab H., Betton M., Tea V., Blanchard A., Bruno R., Hulot J. French COVID cohort study group Cardiac Performance in Patients Hospitalized with COVID-19: A 6 Month Follow-up Study. ESC Heart Fail. 2021;8:2232&#x2013;2239. doi: 10.1002/ehf2.13315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13315</ArticleId><ArticleId IdType="pmc">PMC8120370</ArticleId><ArticleId IdType="pubmed">33773099</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Boon G.J.A.M., Barco S., Endres M., Geelhoed J.J.M., Knauss S., Rezek S.A., Spruit M.A., Vehreschild J., Siegerink B. The Post-COVID-19 Functional Status (PCFS) Scale: A Tool to Measure Functional Status over Time after COVID-19. Eur. Respir. J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>